TY - JOUR T1 - Living donor kidney transplantation: Let's talk about it JF - Clinical Medicine JO - Clin Med SP - 346 LP - 348 DO - 10.7861/clinmed.2020-0047 VL - 20 IS - 3 AU - Videha Sharma AU - Reuben Roy AU - Oana Piscoran AU - Angela Summers AU - David van Dellen AU - Titus Augustine Y1 - 2020/05/01 UR - http://www.rcpjournals.org/content/20/3/346.abstract N2 - Transplantation is the preferred treatment option for end-stage renal disease as it offers superior results and patient reported outcomes in comparison to dialysis. Patients treated with a transplant live longer, healthier and more independent lives. Transplantation is also more cost-effective, reducing the overall burden of renal disease. Despite the rising incidence of renal failure, the uptake of living donor kidney transplantation has been static across the UK for several years. Among transplantation, living donation offers a number of advantages compared with deceased donor transplantation. The procedure is more likely to be performed pre-dialysis and the elective nature allows for better perioperative planning. Awareness for living donation processes among healthcare professionals, patients and the public appears to be poor. Sharing information regarding the process will help educate colleagues, dispel myths and, crucially, allow patients the opportunity to talk about this treatment option with their hospital doctor. ER -